Company Analysis Coloplast A/S
1. Summary
Advantages
- Price (100 $) is less than fair price (114.25 $)
- Dividends (2.66%) are higher than the sector average (2.28%).
- The company's current efficiency (ROE=28.67%) is higher than the sector average (ROE=12.46%)
Disadvantages
- The stock's return over the last year (-22.24%) is lower than the sector average (-3.67%).
- Current debt level 47.07% has increased over 5 years from 1.38%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Coloplast A/S | Healthcare | Index | |
---|---|---|---|
7 days | 6.5% | -7.9% | 0.6% |
90 days | 1.4% | -8.9% | 19.2% |
1 year | -22.2% | -3.7% | 14.2% |
CLPBF vs Sector: Coloplast A/S has significantly underperformed the "Healthcare" sector by -18.57% over the past year.
CLPBF vs Market: Coloplast A/S has significantly underperformed the market by -36.41% over the past year.
Stable price: CLPBF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CLPBF with weekly volatility of -0.4277% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (100 $) is lower than the fair price (114.25 $).
Price not significantly lower than the fair price: The current price (100 $) is slightly lower than the fair price by 14.3%.
4.2. P/E
P/E vs Sector: The company's P/E (39.1) is lower than that of the sector as a whole (54.24).
P/E vs Market: The company's P/E (39.1) is lower than that of the market as a whole (59.87).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (11.01) is higher than that of the sector as a whole (4.2).
P/BV vs Market: The company's P/BV (11.01) is higher than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.31) is higher than that of the sector as a whole (4.62).
P/S vs Market: The company's P/S indicator (7.31) is higher than that of the market as a whole (3.43).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (25.87) is higher than that of the sector as a whole (14.71).
EV/Ebitda vs Market: The company's EV/Ebitda (25.87) is lower than that of the market as a whole (40.12).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.07% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.07%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0.5351%).
5.4. ROE
ROE vs Sector: The company's ROE (28.67%) is higher than that of the sector as a whole (12.46%).
ROE vs Market: The company's ROE (28.67%) is lower than that of the market as a whole (41.73%).
5.5. ROA
ROA vs Sector: The company's ROA (10.5%) is higher than that of the sector as a whole (6.23%).
ROA vs Market: The company's ROA (10.5%) is lower than that of the market as a whole (29.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.99%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.66% is higher than the average for the sector '2.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.66% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 2.66% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (93.43%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription